Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?

Human neutrophils exert a well-known role as efficient effector cells to kill pathogenic micro-organisms. Apart from their role in innate immunity, neutrophils also have the capacity to suppress T cell-mediated immune responses as so-called granulocyte-myeloid-derived suppressor cells (g-MDSCs), imp...

Full description

Bibliographic Details
Main Authors: Cathelijn E. M. Aarts, Ida H. Hiemstra, Charita Furumaya, Robin van Bruggen, Taco W. Kuijpers
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01110/full
_version_ 1818656850985353216
author Cathelijn E. M. Aarts
Ida H. Hiemstra
Charita Furumaya
Robin van Bruggen
Taco W. Kuijpers
Taco W. Kuijpers
author_facet Cathelijn E. M. Aarts
Ida H. Hiemstra
Charita Furumaya
Robin van Bruggen
Taco W. Kuijpers
Taco W. Kuijpers
author_sort Cathelijn E. M. Aarts
collection DOAJ
description Human neutrophils exert a well-known role as efficient effector cells to kill pathogenic micro-organisms. Apart from their role in innate immunity, neutrophils also have the capacity to suppress T cell-mediated immune responses as so-called granulocyte-myeloid-derived suppressor cells (g-MDSCs), impacting the clinical outcome of various disease settings such as cancer. Patients undergoing chemotherapy because of an underlying malignancy can develop prolonged bone marrow suppression and are prone to serious infections because of severe neutropenia. Concentrates of granulocytes for transfusion (GTX) constitute a therapeutic tool and rescue treatment to fight off these serious bacterial and fungal infections when antimicrobial therapy is ineffective. GTX neutrophils are mobilized by overnight G-CSF and/or Dexamethasone stimulation of healthy donors. Although the phenotype of these mobilized neutrophils differs from the circulating neutrophils under normal conditions, their anti-microbial function is still intact. In contrast to the unaltered antimicrobial effector functions, G-CSF/Dexamethasone-mobilized neutrophils were found to lack suppression of the T cell proliferation, whereas G-CSF-mobilized or Dexamethasone-mobilized neutrophils could still suppress the T cell proliferation upon cell activation equally well as control neutrophils. Although the mechanism of how G-CSF/Dex mobilization may silence the g-MDSC activity of neutrophils without downregulating the antimicrobial activity is presently unclear, their combined use in patients in the treatment of underlying malignancies may be beneficial—irrespective of the number of circulating neutrophils. These findings also indicate that MDSC activity does not fully overlap with the antimicrobial activity of human neutrophils and offers the opportunity to elucidate the feature(s) unique to their T-cell suppressive activity.
first_indexed 2024-12-17T03:32:09Z
format Article
id doaj.art-8a4166b4ca5a4aa787d2380a723a16ca
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-17T03:32:09Z
publishDate 2020-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8a4166b4ca5a4aa787d2380a723a16ca2022-12-21T22:05:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-07-011010.3389/fonc.2020.01110543113Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?Cathelijn E. M. Aarts0Ida H. Hiemstra1Charita Furumaya2Robin van Bruggen3Taco W. Kuijpers4Taco W. Kuijpers5Department of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, NetherlandsDepartment of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, NetherlandsDepartment of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, NetherlandsDepartment of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, NetherlandsDepartment of Blood Cell Research, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, NetherlandsDepartment of Pediatric Immunology, Rheumatology & Infectious Diseases, Emma Children's Hospital, AUMC, University of Amsterdam, Amsterdam, NetherlandsHuman neutrophils exert a well-known role as efficient effector cells to kill pathogenic micro-organisms. Apart from their role in innate immunity, neutrophils also have the capacity to suppress T cell-mediated immune responses as so-called granulocyte-myeloid-derived suppressor cells (g-MDSCs), impacting the clinical outcome of various disease settings such as cancer. Patients undergoing chemotherapy because of an underlying malignancy can develop prolonged bone marrow suppression and are prone to serious infections because of severe neutropenia. Concentrates of granulocytes for transfusion (GTX) constitute a therapeutic tool and rescue treatment to fight off these serious bacterial and fungal infections when antimicrobial therapy is ineffective. GTX neutrophils are mobilized by overnight G-CSF and/or Dexamethasone stimulation of healthy donors. Although the phenotype of these mobilized neutrophils differs from the circulating neutrophils under normal conditions, their anti-microbial function is still intact. In contrast to the unaltered antimicrobial effector functions, G-CSF/Dexamethasone-mobilized neutrophils were found to lack suppression of the T cell proliferation, whereas G-CSF-mobilized or Dexamethasone-mobilized neutrophils could still suppress the T cell proliferation upon cell activation equally well as control neutrophils. Although the mechanism of how G-CSF/Dex mobilization may silence the g-MDSC activity of neutrophils without downregulating the antimicrobial activity is presently unclear, their combined use in patients in the treatment of underlying malignancies may be beneficial—irrespective of the number of circulating neutrophils. These findings also indicate that MDSC activity does not fully overlap with the antimicrobial activity of human neutrophils and offers the opportunity to elucidate the feature(s) unique to their T-cell suppressive activity.https://www.frontiersin.org/article/10.3389/fonc.2020.01110/fullneutrophilsMDSC activitygranulocyte transfusionsGTXsmobilized-neutrophils
spellingShingle Cathelijn E. M. Aarts
Ida H. Hiemstra
Charita Furumaya
Robin van Bruggen
Taco W. Kuijpers
Taco W. Kuijpers
Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
Frontiers in Oncology
neutrophils
MDSC activity
granulocyte transfusions
GTXs
mobilized-neutrophils
title Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
title_full Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
title_fullStr Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
title_full_unstemmed Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
title_short Different MDSC Activity of G-CSF/Dexamethasone Mobilized Neutrophils: Benefits to the Patient?
title_sort different mdsc activity of g csf dexamethasone mobilized neutrophils benefits to the patient
topic neutrophils
MDSC activity
granulocyte transfusions
GTXs
mobilized-neutrophils
url https://www.frontiersin.org/article/10.3389/fonc.2020.01110/full
work_keys_str_mv AT cathelijnemaarts differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient
AT idahhiemstra differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient
AT charitafurumaya differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient
AT robinvanbruggen differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient
AT tacowkuijpers differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient
AT tacowkuijpers differentmdscactivityofgcsfdexamethasonemobilizedneutrophilsbenefitstothepatient